Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ebola study reveals long-term health effects
ebola
During the Ebola outbreak in West Africa more than 28,600 people were infected, of which 11,300 died, leaving 17,000 survivors.

Most survivors still showing brain symptoms
 
A new study of 82 Ebola survivors has revealed that most were still suffering from neurological abnormalities more than six months are the initial infection.

US researchers from the National Institute of Neurological Disorders and Stroke (NINDS) studied a group of survivors from Liberia, with an average age of 35.

The most common ongoing symptoms they found were weakness, headaches, memory loss, depressed mood and muscle pain. Two survivors were suicidal and another was having hallucinations.

Common neurological signs found on examination were abnormal eye movements, tremors and abnormal reflexes.

Researchers are in the process of evaluating controls to determine which of these signs are Ebola-specific.

During the Ebola outbreak in West Africa more than 28,600 people were infected, of which 11,300 died, leaving 17,000 survivors.

Study author Lauren Bowen, from the National Institute of Neurological Disorders and Stroke, said: "It is important for us to know how this virus may continue to affect the brain long term".

The research forms part of a larger Prevail III study which follows patients who have had prior Ebola virus diseases, as well as their close contacts. The preliminary findings will be presented at the American Academy of Neurology's 68th annual meeting in Vancouver in April this year. 

Image credit: NIAID/CC BY 2.0

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.